Pages that link to "Q50641929"

The following pages link to Maria Cristina D'Adamo (Q50641929):

Displaying 39 items.

• Episodic ataxia type-1 mutations in the hKv1.1 cytoplasmic pore region alter the gating properties of the channel (Q24533155) (← links)
• New insights into the pathogenesis and therapeutics of episodic ataxia type 1 (Q26782897) (← links)
• Gain-of-function defects of astrocytic Kir4.1 channels in children with autism spectrum disorders and epilepsy. (Q27340721) (← links)
• Functional characterization of an episodic ataxia type-1 mutation occurring in the S1 segment of hKv1.1 channels (Q28178348) (← links)
• A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1 (Q28297731) (← links)
• Contribution of the central hydrophobic residue in the PXP motif of voltage-dependent K+ channels to S6 flexibility and gating properties (Q28308273) (← links)
• Experimental arterial thrombosis in genetically or diet induced hyperlipidemia in rats--role of vitamin K-dependent clotting factors and prevention by low-intensity oral anticoagulation (Q28572520) (← links)
• K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy (Q30449041) (← links)
• A method to identify tissue cell subpopulations with distinct multi-molecular profiles from data on co-localization of two markers at a time: the case of sensory ganglia. (Q30730924) (← links)
• Genetic Inactivation of Kcnj16 Identifies Kir5.1 as an Important Determinant of Neuronal PCO2/pH Sensitivity (Q34452480) (← links)
• Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene (Q34969098) (← links)
• Expression and function of a CP339,818-sensitive K⁺ current in a subpopulation of putative nociceptive neurons from adult mouse trigeminal ganglia. (Q35560153) (← links)
• A Calsequestrin-1 Mutation Associated with a Skeletal Muscle Disease Alters Sarcoplasmic Ca2+ Release (Q36022588) (← links)
• De novo point mutations in patients diagnosed with ataxic cerebral palsy. (Q36066674) (← links)
• 5-HT2 receptors-mediated modulation of voltage-gated K+ channels and neurophysiopathological correlates. (Q38109032) (← links)
• Update on the implication of potassium channels in autism: K(+) channelautism spectrum disorder (Q38382507) (← links)
• Reconciling the discrepancies on the involvement of large-conductance Ca(2+)-activated K channels in glioblastoma cell migration (Q38459206) (← links)
• Genetically induced dysfunctions of Kir2.1 channels: implications for short QT3 syndrome and autism-epilepsy phenotype. (Q38998704) (← links)
• KCNA4 deficiency leads to a syndrome of abnormal striatum, congenital cataract and intellectual disability (Q40599284) (← links)
• The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma. (Q41495146) (← links)
• Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein. (Q43936916) (← links)
• Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1. (Q48427774) (← links)
• Episodic ataxia type 1 mutations affect fast inactivation of K+ channels by a reduction in either subunit surface expression or affinity for inactivation domain. (Q48681599) (← links)
• Autism with seizures and intellectual disability: possible causative role of gain-of-function of the inwardly-rectifying K+ channel Kir4.1. (Q50311643) (← links)
• Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast inactivation properties of the human potassium channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2. (Q50641836) (← links)
• Role of receptor protein tyrosine phosphatase alpha (RPTPalpha) and tyrosine phosphorylation in the serotonergic inhibition of voltage-dependent potassium channels (Q50718561) (← links)
• Neutrophil derived cathepsin G induces potentially thrombogenic changes in human endothelial cells: a scanning electron microscopy study in static and dynamic conditions. (Q52512661) (← links)
• Erratum: K+ channelepsy: progress in the neurobiology of potassium channels and epilepsy. (Q55710806) (← links)
• Morphological and hemostatic changes in rats with abdominal arterial prosthesis (Q59697077) (← links)
• The adrenergic mechanisms of acute t-PA release in normal and diseased animals (Q59697181) (← links)
• Different response of vascular fibrinolysis to adrenergic stimulation in young and aged rats (Q59697214) (← links)
• Amiloride inhibits tissue-type plasminogen activator (t-PA) release from vascular endothelium (Q70960546) (← links)
• Enhanced vascular plasminogen activator (t-PA) release by epinephrine in aged rats (Q71543635) (← links)
• Prostacyclin is required for t-PA release after venous occlusion (Q71615808) (← links)
• Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis (Q71912334) (← links)
• Effects of dyslipidemia on t-PA release in rats (Q73139513) (← links)
• Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches (Q93211698) (← links)
• Altered functional properties of a missense variant in the TRESK K+ channel (KCNK18) associated with migraine and intellectual disability (Q94564876) (← links)
• Electromechanical coupling of the Kv1.1 voltage-gated K+ channel is fine-tuned by the simplest amino acid residue in the S4-S5 linker (Q96643273) (← links)